| Literature DB >> 36101451 |
Marcelo Tuesta1,2, Rodrigo Yáñez-Sepúlveda3,4, Humberto Verdugo-Marchese2, Cristián Mateluna5, Ildefonso Alvear-Ordenes3.
Abstract
Using muscle oxygenation to evaluate the therapeutic effects of physical exercise in pathologies through near-infrared spectroscopy (NIRS) is of great interest. The aim of this review was to highlight the use of muscle oxygenation in exercise interventions in clinical trials and to present the technological characteristics related to the equipment used in these studies. PubMed, WOS, and Scopus databases were reviewed up to December 2021. Scientific articles that evaluated muscle oxygenation after exercise interventions in the sick adult population were selected. The PEDro scale was used to analyze the risk of bias (internal validity). The results were presented grouped in tables considering the risk of bias scores, characteristics of the devices, and the effects of exercise on muscle oxygenation. All the stages were carried out using preferred reporting items for systematic reviews and meta-analyses (PRISMA). The search strategy yielded 820 clinical studies, of which 18 met the eligibility criteria. This review detailed the characteristics of 11 NIRS devices used in clinical trials that used physical exercise as an intervention. The use of this technology made it possible to observe changes in muscle oxygenation/deoxygenation parameters such as tissue saturation, oxyhemoglobin, total hemoglobin, and deoxyhemoglobin in clinical trials of patients with chronic disease. It was concluded that NIRS is a non-invasive method that can be used in clinical studies to detect the effects of physical exercise training on muscle oxygenation, hemodynamics, and metabolism. It will be necessary to unify criteria such as the measurement site, frequency, wavelength, and variables for analysis. This will make it possible to compare different models of exercise/training in terms of time, intensity, frequency, and type to obtain more precise conclusions about their benefits for patients.Entities:
Keywords: NIRS; hemoglobin; muscle oximetry; physical exercise
Year: 2022 PMID: 36101451 PMCID: PMC9312707 DOI: 10.3390/biology11071073
Source DB: PubMed Journal: Biology (Basel) ISSN: 2079-7737
Figure 1Flow diagram (PRISMA) of the item selection process.
Search strategy in clinical studies.
| Steps | Strategy | PubMed (444) | WoS (47) | Scopus (302) |
|---|---|---|---|---|
| 1 | Spectroscopy, Near-Infrared | 1101 | 473 | 1621 |
| 2 | NIRS | 417 | 150 | 558 |
| 3 | Exercise | 65,369 | 21,026 | 81,580 |
| 4 | Exercise therapy | 33,931 | 1299 | 14,021 |
| 5 | Physical exertion | 5735 | 58 | 1050 |
| 6 | Physical Fitness | 6696 | 543 | 3968 |
| 7 | Sports | 34,562 | 2502 | 9176 |
| 8 | Exercise Movement Techniques | 2820 | 24 | 321 |
| 9 | #3 OR #4 OR #5 OR #6 OR #7 OR #8 | 74,620 | 24,939 | 87,414 |
| 10 | #1 AND #9 | 343 | 37 | 246 |
| 11 | #2 AND #9 | 101 | 10 | 83 |
Quality scores of the PEDro scale applied to exercise clinical trials.
| Studies | PEDro Quality Criteria | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selection | Comparability | Results | Rating | Quality | |||||||||
| 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | |||
| Baker et al., 2017 [ | Yes | Yes | No | Yes | No | No | No | Yes | Yes | Yes | Yes | 6 | Medium |
| Beckitt et al., 2012 [ | Yes | No | No | Yes | No | No | No | Yes | Yes | No | Yes | 4 | Medium |
| Collins et al., 2012 [ | Yes | Yes | Yes | Yes | No | No | No | No | Yes | Yes | Yes | 6 | Medium |
| Fu et al., 2013 [ | Yes | Yes | No | Yes | No | No | No | Yes | Yes | Yes | Yes | 6 | Medium |
| Gardner et al., 2014 [ | Yes | Yes | Yes | Yes | No | No | No | Yes | Yes | Yes | Yes | 7 | Medium |
| Gildea et al., 2021 [ | Yes | Yes | Yes | Yes | No | No | No | Yes | Yes | Yes | Yes | 7 | Medium |
| Guimarães et al., 2021 [ | Yes | Yes | No | Yes | No | No | No | Yes | Yes | Yes | Yes | 6 | Medium |
| Kuge et al., 2005 [ | Yes | No | No | Yes | No | No | No | Yes | Yes | Yes | Yes | 5 | Medium |
| Manfredini et al., 2012 [ | Yes | No | No | Yes | No | No | No | Yes | Yes | Yes | Yes | 5 | Medium |
| Manfredini et al., 2015 [ | Yes | Yes | No | Yes | No | No | No | Yes | Yes | Yes | Yes | 6 | Medium |
| Manfredini et al., 2020 [ | Yes | Yes | No | Yes | No | No | No | Yes | Yes | Yes | Yes | 6 | Medium |
| Mezzani et al., 2013 [ | Yes | Yes | No | Yes | No | No | Yes | Yes | Yes | Yes | Yes | 7 | Medium |
| Monteiro et al., 2019 [ | Yes | Yes | No | Yes | No | No | Yes | No | Yes | Yes | Yes | 6 | Medium |
| Olivier et al., 2010 [ | Yes | Yes | No | Yes | No | No | No | Yes | Yes | Yes | Yes | 6 | Medium |
| Porcelli et al., 2016 [ | Yes | No | No | Yes | No | No | No | Yes | Yes | Yes | Yes | 5 | Medium |
| Søgaard et al., 2012 [ | Yes | Yes | No | Yes | No | No | No | Yes | Yes | No | Yes | 5 | Medium |
| Takagi et al., 2016 [ | Yes | No | No | Yes | No | No | No | Yes | Yes | Yes | Yes | 5 | Medium |
| Tew et al., 2009 [ | Yes | Yes | Yes | Yes | No | No | No | Yes | Yes | Yes | Yes | 7 | Medium |
Characteristics of NIRS devices used in exercise clinical trials.
| NIRS Device (Trademark, Model) | Technique | Measurements (Units) | Wavelength (nm) | Research Articles (Reference) |
|---|---|---|---|---|
| Artinis Medical Systems | ||||
| Portamon | CW, multi-distance | TSI (%), ∆HHb, ∆O2Hb, ∆tHb. | 750, 760, 841, 850 | [ |
| Oxymon Mk-III | CW, multi-distance | TSI (%), ∆HHb, ∆O2Hb, ∆tHb | 765, 770, 850, 905 | [ |
| Astem Co | ||||
| NIR srs Hb11 | CW, multi-distance | StO2 (%), ∆HHb, ∆O2Hb, ∆tHb | 770, 830 | [ |
| Hamamatsu Photonics K.K. | ||||
| NIRO-300 | CW, multi-distance | TOI (%), ∆HHb, ∆O2Hb, ∆tHb (μmol) | 776, 826, 845, 905 | [ |
| NIRO-200 | CW, multi-distance | TOI (%), ∆HHb, ∆O2Hb, ∆tHb (μmol) | 735, 810, 850 | [ |
| Hutchinson Technology Inc. | ||||
| Inspectra Spectrometer 325 | CW, multi-distance | StO2 (%) | 680, 720, 760, 800 | [ |
| NIM Inc. | ||||
| CW, multi-distance | StO2 (%), ∆HHb, ∆O2Hb, ∆tHb (arbitrary units) | 730, 850 | [ | |
| OMEGA | ||||
| BOM-L1TR | CW, multi-distance | StO2 (%), ∆HHb, ∆O2Hb, ∆tHb (μmol) | 730, 810, 830 | [ |
| OMRON | ||||
| HEO-100 | CW, single-distance | ∆HHb, ∆O2Hb, ∆tHb (%) | 760, 840 | [ |
| Thorlabs | ||||
| DCS FD-NIRS | FD, multi-distance | StO2 (%), aHHb, aO2Hb, atHb (μmol) | 685, 785, 830 | [ |
| SS Inc., Champaign, IL | ||||
| Oxiplex TS | FD, multi-distance | SO2m (%), aHHb, aO2Hb, atHb (μmol) | 692, 834 | [ |
∆: relative changes; a: absolute changes; CW: continuous wave; FD: frequency domain; HHb: deoxyhemoglobin; O2Hb: oxyhemoglobin; tHb: total hemoglobin; SO2m/StO2/TOI/TSI: muscle oxyhemoglobin saturation.
Clinical trials with exercise training that analyzed oxygenation, blood flow, and muscle metabolism with NIRS.
| Author | Oxygenation Objective | Participants | Training Protocols | Intervention Length | Sampling Area | Results after Training Protocol |
|---|---|---|---|---|---|---|
| Baker et al., 2017 [ | AET on microvascular blood flow and muscle oxygen extraction in PAD | 64 pt. with PAD. | AET: 60 min of treadmill walking intervals at 2 mph with increasing gradient (2%/2 min) until claudication. CON: non-exercise | 3 ses/wk/ | Gastrocnemius | AET: Higher blood flow and oxygen desaturation during maximal exercise test. CON: without changes |
| Beckitt et al., 2012 [ | Exercise training (ET) versus angioplasty (AG) on oxygen muscle saturation in stable claudication patients | 56 pt. with stable claudication PAD. ET ( | ET: 10′ warm-up, 5 station circuit, 8′ each station. AG: angioplasty without exercise | 2 ses/wk/ | Lateral gastrocnemius | ET and AG: Higher reoxygenation during recovery after an ischemia occlusion |
| Collins et al., 2012 [ | Oxygen muscle saturation in PAD after a TWP versus a WPP exercise program in PAD | 85 pt. with PAD. | TWP and WPP: 9 wk. for 6 min at 25–44% VO2peak (LIn), 18 min at 45–59% VO2peak (MIn), and 6 min at 60–84% VO2peak (HI) according to maximal pain tolerance. Following ~3 wk, pt. walked for 5.5 min at LI, ~25 min at MI, and ~25 min at HI (WPP: with poles) | 3 ses/wk/ | Medial gastrocnemius | TWP: Higher muscle saturation during submaximal intensity in a treadmill exercise test. WWP: without changes |
| Fu et al., 2013 [ | MCT and AIT on central and peripheral hemodynamics in heart failure (HF) | 45 pt. with HF. AIT ( | AIT: Five cycling intervals of 3 min at 80%, VO2peak interspersed with 5 intervals of 3 min at 30% VO2max. | 3 ses/wk/ | Vastus lateralis quadriceps | AIT: Higher oxygen extraction muscle during all exercise in a maximal test. CON: without changes |
| Gardner et al., 2014 [ | Muscle oxygenation in PAD after supervised exercise training (SET), home-exercise program (HEP), or an attention control group (CON) | 180 pt. with PAD. SET ( | SET: ITW to mild-to-moderate claudication pain at a speed of 2 mph at 40% maximal power output in maximal treadmill test with increase from 15 to 40 min. HEP: ITW to mild-to-moderate claudication pain at a self-selected pace with a step monitor, increasing 20 to 45 min per session. CON: non-exercise | 3 ses/wk/ | Gastrocnemius | SET and HEP: Higher saturation level during submaximal intensity exercise and at half time during resting recovery. CON: without changes |
| Gildea et al., 2021 [ | Muscle VO2 and oxygenation kinetics after HIIT and MCT in T2D | 28 pt. with T2D. MCT ( | MCT: 50 min moderate-intensity cycling. HIIT: 10 reps of 1 min at 90% HRmax. CON: non-exercise | 3 ses/wk/ | Vastus lateralis quadriceps | HIIT and MCT: Improved the VO2 kinetics (↓ tau) and decreased muscle deoxygenation (↓ ∆[HHb + Mb]/dVO2) during exercise. CON: without changes |
| Guimaraes et al., 2021 [ | AET plus resistance training (ART) on peripheral muscular performance and muscle oxygenation in HF | 24 pt. with HF. HF-ART ( | HF-ART: 30 min of AET on cycle ergometer at CRP and 1 set of 10–15 reps (intensity 13–15 Borg scale) in 5 different resistance exercises. HF-CON: non-exercise | 3 ses/wk/ | Vastus lateralis quadriceps | HF-ART: Higher muscle oxygenation (↓Oxy-Hb, ↓ deoxy-Hb, and ↓ tHB) during peak in an exercise test. HF-CON: without changes |
| Kuge et al., 2005 [ | Vasodilator response, muscle oxygenation, and performance post exercise in hemodialysis patients (HP) by CKD | 15 subjects. | HP: Handgrip training for 4 d/wk during 6 wk (15 to 30 min app.). 50 reps at 60% MVC during 1st wk, increasing 20 reps/wk until reaching 150 reps. | 4 ses/wk/ | Flexor digitorum superficialis | HP: Without changes in vasodilator response (↔[tHb]) but a higher |
| Manfredini et al., 2012 [ | Structured (SW) versus unstructured walking (UW) program exercise on hemodynamic, functional, and muscle VO2 | 45 pt. with PAD. SW ( | SW: 2 rep/d of 10 min of walking at 20–30% below pain threshold speed. UW: free walking 20 to 30 min/d to a moderate level of pain. CON: non-exercise | 6 ses/wk/ | Medial gastrocnemius | SW: Increased the mVO2 (↑ the rate of increase in (HHb) during venous occlusion) to healthy subject values and perfusion (ABI) at rest, indicating normalized muscle function. Increased the distance to claudication during exercise. UW: without changes |
| Manfredini et al., 2015 [ | Walking exercise on resting mVO2 and vascular function in myopathy for end-stage renal disease (ESRD) | 54 pt. myopathy by ESRD. EXP ( | EXP: 2 rep/d of 10 min of walking at 70–120% of maximum walking speed. | 4 ses/wk/ | Medial gastrocnemius | EXP: Decreased the mVO2 (idem [ |
| Manfredini et al., 2020 [ | Robot (RO)- and physiotherapist (PT)- assisted walking on mVO2 in multiple sclerosis (MS) | 46 pt. with MS and 10 control healthy subjects. MS-RO ( | MS-RO: 40 min of robot-assisted walking. MS-PT: 40 min of walking assisted by physiotherapists. CON: non-exercise | 2 ses/wk/ | Medial gastrocnemius | MS-RO: Decreased the mVO2 rest (idem [ |
| Mezzani et al., 2013 [ | AET effects on pulmonary and muscle VO2 kinetics in heart failure | 30 pt. with HF and 7 healthy subjects. HF-AET ( | HF-EXP: 30 min cycling exercise at ventilatory threshold 1. HF-CON: habitual lifestyle and activities without a formal training protocol. H-CON: non-exercise | 5 ses/wk/ | Vastus lateralis quadriceps | HF-EXP: Decreased pulmonary time delay of VO2 kinetics during submaximal steady-state exercise and increased peak oxygen extraction in muscle during maximal exercise test (↑ peak ∆[HHB]). HF-CON: without changes |
| Monteiro et al., 2019 [ | Muscle oxygenation in PAD after MCT versus modified aerobic training (MAT) with a load on the lower limbs | 40 pt. with PADMCT ( | MCT: 30 min of walking on the floor and 30 min on treadmill at floor walking speed without inclination (increase of 0.2 km/h with the cessation of symptoms). MAT: 15 min of walking on the floor with ankle weights (increase progressively from 0.5 to 2 kg). Both trainings were symptoms controlled | 3 ses/wk/ | Medial gastrocnemius | MCT and MAT: Decrease the rate of muscle desaturation (StO2) with MCT > MAT. MCT: Higher muscle saturation during maximal exercise test (↑ in exercise test duration) |
| Olivier et al., 2010 [ | One leg cycling training on leg muscle oxygenation (LMO2) in soccer players with anterior cruciate ligament reconstruction | 24 regional-level soccer players with ACLR. | EXP: 21 min alternating 3 min at 70% HRmax and 3 min at 85% HRmax. CON: familiarization training during 10 min at 30 W | 3 ses (CON: 1 ses)/wk/ | Vastus lateralis quadriceps | EXP: Increased in LMO2 (relative change in the oxy/deoxy hemoglobin/myoglobin) and |
| Porcelli et al., 2016 [ | Home-based AET on muscle oxygen uptake and fractional O2 extraction in mitochondrial myopathies (MM) and McArdle’s disease (McA) | 13 patients with mitochondrial myopathies. MM ( | MM and McA: 30 min of cycling (wk 1–6) and 45 min (wk 7–12) at 65–70% of HRmax | 4 ses/wk/ | Vastus lateralis quadriceps | MM and McA: Higher changes in skeletal muscle fractional O2 extraction (deoxy(Hb + Mb)) during exercise |
| Søgaard et al., 2012 [ | General fitness training (GFT) performed as leg bicycling versus strength training (ST) on muscle oxygenation in trapezius with chronic myalgia | 39 pt. with trapezius myalgia. GAT ( | GFT: 20′ at 50–70% of VO2max. | 3 ses/wk/ 2.5 mo | Trapezius muscle | GFT: Higher blood flow (↑ in O2Hb and tHB) during pegboard exercise. CON: without changes |
| Takagi et al., 2016 [ | AET on muscle deoxygenation and VO2peak in post-myocardial infarction (AMI) | 16 pt. with AMI. AET ( | AET: 10 W below LT, 30’ x 10′ warm up and 10′ cool down. CON: non-exercise | 2 ses/wk/ | Vastus lateralis quadriceps | AET: Higher muscle oxigenation (↓ SmO2 and ↑ deoxy-Hb) during submaximal and peak intensity in a maximal exercise test. CON: without changes |
| Tew et al., 2009 [ | Arm-crank exercise (ACE) training on lower-limb O2 delivery in patients with intermittent claudication | 57 pt. with PAD. ACE ( | ACE: Cycles of 2 min exercise at a crank rate of 50 rev/min at 60–70% of the peak work rate in an incremental arm-crank test followed by 2 min of rest for a total exercise time of 20 min in a 40 min session. CON: non-exercise | 2 ses/wk/ | Gastrocnemius | ACE: Higher submaximal oxygenation (↑ StO2) during maximal exercise testing. CON: without changes |
ABI: Ankle-brachial index; AET: Aerobic exercise training; AIT: Aerobic interval training; CKD: Chronic kidney disease; CON: Control group; EXP: Experimental group; HI: High intensity; HIIT: High-intensity interval training; ITW: Intermittent treadmill walking; LIn: Light intensity; MIn: Moderate intensity; MCT: Moderate continuous training; MVC: Maximal voluntary contraction; mVO2: Muscular oxygen consumption; PAD: Peripheral arterial disease; RCP: Respiratory compensation point; T2D: Type 2 diabetes mellitus: TWP: Traditional walking program; WPP: Walking-with-poles program. ↑ or ↓: significant changes; ↔: no significant changes.